Pfizer Experts Escape Judge's Boot In Neurontin Case

Law360, New York (February 16, 2010, 6:36 PM EST) -- A judge has rejected Kaiser Foundation Health Plan Inc.’s attempt to strike the testimony of a group of experts for Pfizer Inc. ahead of a trial over the drugmaker’s alleged off-label promotion of Neurontin, contending that there is simply not enough time to address Kaiser’s concerns.

Judge Patti B. Saris issued an order Friday in the U.S. District Court for the District of Massachusetts denying five of Kaiser’s motions to exclude the testimony of Pfizer's efficacy experts from the upcoming trial, which is scheduled to start...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.